Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT GLENMARK PHARMA WOCKHARDT/
GLENMARK PHARMA
 
P/E (TTM) x -12.0 12.2 - View Chart
P/BV x 0.9 1.6 55.9% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 WOCKHARDT   GLENMARK PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-22
GLENMARK PHARMA
Mar-21
WOCKHARDT/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs805573 140.5%   
Low Rs253195 129.6%   
Sales per share (Unadj.) Rs224.3387.8 57.8%  
Earnings per share (Unadj.) Rs-19.434.4 -56.3%  
Cash flow per share (Unadj.) Rs-2.250.1 -4.4%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs266.0249.6 106.6%  
Shares outstanding (eoy) m144.03282.17 51.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.41.0 238.2%   
Avg P/E ratio x-27.311.2 -244.4%  
P/CF ratio (eoy) x-238.07.7 -3,105.4%  
Price / Book Value ratio x2.01.5 129.2%  
Dividend payout %07.3 0.0%   
Avg Mkt Cap Rs m76,168108,353 70.3%   
No. of employees `000NANA-   
Total wages/salary Rs m7,49023,437 32.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,300109,439 29.5%  
Other income Rs m200502 39.8%   
Total revenues Rs m32,500109,941 29.6%   
Gross profit Rs m1,15021,289 5.4%  
Depreciation Rs m2,4704,436 55.7%   
Interest Rs m2,9903,531 84.7%   
Profit before tax Rs m-4,11013,825 -29.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,3204,124 -32.0%   
Profit after tax Rs m-2,7909,701 -28.8%  
Gross profit margin %3.619.5 18.3%  
Effective tax rate %32.129.8 107.7%   
Net profit margin %-8.68.9 -97.4%  
BALANCE SHEET DATA
Current assets Rs m25,89073,596 35.2%   
Current liabilities Rs m32,07042,010 76.3%   
Net working cap to sales %-19.128.9 -66.3%  
Current ratio x0.81.8 46.1%  
Inventory Days Days317 472.1%  
Debtors Days Days1086 12.1%  
Net fixed assets Rs m50,81067,093 75.7%   
Share capital Rs m720282 255.2%   
"Free" reserves Rs m37,59070,148 53.6%   
Net worth Rs m38,31070,430 54.4%   
Long term debt Rs m3,55038,888 9.1%   
Total assets Rs m76,700140,689 54.5%  
Interest coverage x-0.44.9 -7.6%   
Debt to equity ratio x0.10.6 16.8%  
Sales to assets ratio x0.40.8 54.1%   
Return on assets %0.39.4 2.8%  
Return on equity %-7.313.8 -52.9%  
Return on capital %-2.715.9 -16.9%  
Exports to sales %00-   
Imports to sales %1.90-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m624NA-   
Fx inflow Rs m2,26335,753 6.3%   
Fx outflow Rs m62412,023 5.2%   
Net fx Rs m1,63823,729 6.9%   
CASH FLOW
From Operations Rs m4,13011,312 36.5%  
From Investments Rs m-2,010-6,752 29.8%  
From Financial Activity Rs m-710-4,418 16.1%  
Net Cashflow Rs m1,380278 496.0%  

Share Holding

Indian Promoters % 65.8 46.7 140.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 34.7 8.4%  
FIIs % 2.8 24.2 11.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 34.3 53.4 64.2%  
Shareholders   180,170 312,473 57.7%  
Pledged promoter(s) holding % 47.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    



Today's Market

Sensex Zooms 515 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian share markets rose today tracking the rally in US stocks after softer-than-expected US inflation data stoked speculation the Federal Reserve could pivot to a shallower pace of interest-rate hikes.